5:03 PM
 | 
Feb 12, 2018
 |  BC Extra  |  Company News

Axovant falls as CEO, president depart

Editor's Note: This article was updated on Feb 13, 2018 at 4:00 PM PST

Axovant Sciences Ltd. (NASDAQ:AXON) fell $0.38 (20%) to $1.54 on Monday after it shuffled its management team and board of directors. The neurology company said David Hung resigned as CEO and a director to pursue other opportunities....

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >